ELIZABETH WEESNER; HOSAIN GHASSEMI; IRYNA SALAPENKA; JAYA SRI KONAKANCHI; GREGORY MAGGIO; SETHI, Roopa. Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration. Kansas Journal of Medicine, [S. l.], v. 15, n. 2, p. 302–304, 2022. DOI: 10.17161/kjm.vol15.17931. Disponível em: https://journals.ku.edu/kjm/article/view/17931.. Acesso em: 7 may. 2024.